3 completed, 1 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Adenoma, Liver Cell: new trials by email Literature Review of Adenoma, Liver Cell trials Research Report on Adenoma, Liver Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients Garcinia cambogia rind powder - Lipid Profile | Not applicable | Completed | University of Lahore | 90 | 2025-09-01 | 2026-02-18 |
| A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas Baricitinib - Inflammatory Hepatocellular Adenoma | Phase 2 | Recruiting | Assistance Publique - Hôpitaux de Paris | 25 | 2024-10-02 | 2025-12-26 |
| Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry Optimized Internal Radiation Therapy, Standard Internal Radiation Therapy - Adenoma, Liver Cell | Phase 2 | Completed | Center Eugene Marquis | 56 | 2015-12-01 | 2019-01-31 |
| Sorafenib and TRC105 in Hepatocellular Cancer TRC 105, Sorafenib - Hepatoma, Liver Neoplasms | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2011-02-11 | 2019-01-23 |
Carcinoma, Hepatocellular (1) · Glucose Intolerance (1) · Liver Neoplasms (1) · Liver Neoplasms, Experimental (1) · Obesity (1)
Adenoma (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Liver Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Liver Neoplasms (3) · Adenocarcinoma (1) · Body Weight (1) · Carcinoma (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Metabolic Diseases (1)
Sorafenib (1) · baricitinib (1) · carotuximab (1)
Assistance Publique - Hôpitaux de Paris (1) · Center Eugene Marquis (1) · National Cancer Institute (NCI) (1) · University of Lahore (1)
France (2) · Pakistan (1) · United States (1)